SQUARER RON

PrivateCIK: 1454001
Location

SAN DIEGO, CA

SQUARER RON (CEO) reported 2 transactions at ARRAY BIOPHARMA INC

Review the transaction codes below to understand the nature of each event.

InsiderSQUARER RONCIK 1454001
IssuerARRAY BIOPHARMA INCCIK 1100412
DirectorOfficer· CEO
Since Dec 2018
-3.86M
Net shares
Net seller
$12.47M
Total sold
0
Open market trades
0B · 0S
9
Total transactions
3.86M disposed
Non-Derivative Transactions2

Common Stock

Direct
D · Disposition

Shares

259.89K

Price / share

$48.00

Trade value

$12.47M

% of position

37.0%
7/30/2019
702.08K442.19K

Common Stock

Direct
D · Disposition

Shares

442.19K

Price / share

Trade value

% of position

New position
7/30/2019
442.19K0.00
Total

Net shares

702.08K

Net value

-$12.47M

Derivative Transactions7

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

545.82K shares

Shares

545.82K

Strike price

3.61

Held after

0.00

Exercisable

7/30/2019

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

345.31K shares

Shares

345.31K

Strike price

4.63

Held after

0.00

Exercisable

7/30/2019

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

113.44K shares

Shares

113.44K

Strike price

7.30

Held after

0.00

Exercisable

7/30/2019

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

453.75K shares

Shares

453.75K

Strike price

3.00

Held after

0.00

Exercisable

7/30/2019

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

421.88K shares

Shares

421.88K

Strike price

8.79

Held after

0.00

Exercisable

7/30/2019

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

600K shares

Shares

600K

Strike price

10.92

Held after

0.00

Exercisable

7/30/2019

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

678.75K shares

Shares

678.75K

Strike price

15.97

Held after

0.00

Exercisable

7/30/2019
SQUARER RON — Insider Transaction (Form 4) Filed Jul 30, 2019 | Finecho